We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

EU Says Pay-For-Delay Drug Settlements Still Down

Law360 (March 12, 2018, 5:02 PM EDT) -- European Union pay-for-delay settlements between brand pharmaceutical companies and their generic competitors to restrict generic entry into the market “have stabilized at a low level,” European Commission antitrust regulators concluded in a...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.